UK Life Sciences Company Directory

Global pharma company in oncology, immunology, and neuroscience

Johnson & Johnson is a multinational pharmaceutical company with UK operations spanning commercial, medical affairs, and innovation activities. Its Innovative Medicine division covers oncology, immunology, neuroscience, and infectious disease. The company operates an EMEA Innovation Centre in London focused on…

Bacteriophage antimicrobials targeting livestock pathogens to replace antibiotics

Aparon is a biotechnology company developing bacteriophage-based technologies as novel antimicrobials for use in livestock production. Its research focuses on identifying and formulating bacteriophage cocktails that selectively destroy bacterial pathogens in animals, offering an alternative to conventional antibiotic…

API development and manufacturing for pharmaceutical drug substances

Aptuit is a pharmaceutical chemical development and manufacturing site operating as part of Evotec's API and drug product network. The company develops and manufactures active pharmaceutical ingredients for small molecule drugs, offering route scouting, process development and scale-up, polymorph screening, analytical…

Preclinical vaccines targeting antimicrobial-resistant bacterial infections

VacTimmune is a biotechnology company developing preventative vaccines against bacterial pathogens associated with antimicrobial resistance. Its preclinical pipeline includes candidates targeting Pseudomonas aeruginosa, Klebsiella pneumoniae and other clinically important bacteria, with an emphasis on infections…

Peptide immunotherapies for the treatment of food allergy

Aravax is a clinical-stage biotechnology company developing next-generation specific immunotherapies for food allergy. Its lead candidate, PVX108, is a synthetic peptide-based therapy designed to desensitise peanut-allergic patients by targeting the T cells that drive allergic responses, without triggering acute…

Antibody therapies targeting severe autoimmune diseases

argenx UK Ltd is the UK commercial subsidiary of argenx SE, a global immunology company developing antibody-based therapies for severe autoimmune diseases. The company markets VYVGART (efgartigimod), the first approved FcRn blocker in the UK, indicated for generalised myasthenia gravis and chronic inflammatory…

AAV gene therapy platform and clinical pipeline for genetic disease

AskBio UK Ltd is the European headquarters of AskBio Inc., a fully integrated AAV gene therapy company and Bayer AG subsidiary. Operating from Roslin Innovation Centre, the Edinburgh site develops the company's synthetic promoter technology, data-driven gene expression control sequences that complement AskBio's Pro10…

Custom modified oligonucleotides for research and therapeutics

ATDBio is a University of Southampton spin-out specialising in custom DNA and RNA oligonucleotide synthesis for research, diagnostics and therapeutic development. Its Southampton-based operations supply standard and chemically modified oligos, including antisense sequences, siRNA, aptamers and labelled probes, using…

Blood glycomic biomarkers for chronic inflammatory disease detection and monitoring

Avenna is a biotechnology company developing blood-based glycomic biomarkers for chronic inflammatory diseases. Its tests analyse the sugar structures attached to blood proteins to measure chronic inflammation separately from short-term acute inflammation, supporting early detection, disease monitoring and…

Microfluidic avidity platform for preclinical cell therapy validation

Avigen is a contract research organisation providing preclinical validation services for cellular immunotherapies using a proprietary microfluidic platform. The platform measures cellular avidity, the total binding strength between immune and cancer cells, at high throughput using fluid shear stress, enabling…

Molecular biology reagents and enzymes for diagnostic and biotech applications

Apto-Gen is a UK manufacturer of high-performance enzymes and molecular biology reagents for integration into PCR, qPCR, NGS, and isothermal amplification assays. Its products serve human diagnostics, veterinary diagnostics, food safety, and environmental testing customers, and are designed for direct integration into…

Liver-directed RNA medicines to restore function in chronic liver disease

Apterna is a preclinical biotechnology company developing RNA-based medicines to restore function in damaged livers. Its lead programme is a liver-directed therapy, given by injection under the skin every few months, that silences a single gene which limits the liver's ability to recover from injury. Animal studies…

Academic drug discovery accelerator developing small molecule therapeutics

Slingshot Therapeutics is a drug discovery accelerator that identifies early-stage scientific programmes from academic institutions and advances them towards clinical development. The company provides centralised expertise, operational infrastructure, and funding to progress small molecule candidates through…

Hypothermic gel preservation technology for shipping cells

Atelerix is a biotechnology company supplying hydrogel-based cell and tissue preservation products that eliminate the need for cryogenic cold chain logistics. Its patented alginate encapsulation technology maintains cell viability at ambient temperatures for up to fourteen days, enabling the shipment of cells,…

Sterile injectable drug manufacturing and fill-finish for global pharma

Patheon is a contract development and manufacturing site operating as part of Thermo Fisher Scientific's Pharma Services business. The site specialises in sterile liquid and freeze-dried injectable products, including high potency medicines and large volume parenterals, offering development, commercial manufacturing,…

Clinical trial development, early-phase research and regulatory consulting

Parexel is a global contract research organisation providing clinical trial delivery, early-phase research, regulatory consulting, biostatistics and pharmacovigilance services to pharmaceutical and biotechnology companies. Its UK operations include a 45-bed early-phase clinical unit at Northwick Park Hospital in…

Connecting UK bioinformatics data services, standards and training

ELIXIR-UK is the United Kingdom's national node of ELIXIR, a distributed European infrastructure supporting biological data research. Coordinated from the Earlham Institute, it connects universities and research organisations that develop and maintain bioinformatics tools, datasets, standards and training. The network…

Stabilised siRNA therapeutics platform targeting cardiovascular gene silencing

Argonaute RNA is a biopharmaceutical company developing small interfering RNA therapeutics for cardiovascular disease. Its siRNA platform uses proprietary chemical stabilisation to enable safe, targeted and temporary gene silencing in specific tissue cells, overcoming delivery and safety barriers that have constrained…

Bioactive molecule delivery technologies for cell culture and therapeutics

Cell Guidance Systems is a biotech and reagents company developing technologies for the delivery of bioactive molecules, with applications in cell biology research, drug development, and biomanufacturing. Its technology addresses protein instability in cell culture by providing sustained, localised release of growth…

European hub for RNAi therapeutics developer

Alnylam UK is the European operational headquarters of Alnylam Pharmaceuticals, the pioneer of RNA interference therapeutics. Based in Maidenhead, the UK office serves as Alnylam's primary base for European commercial operations, medical affairs, and regulatory activities. Alnylam has six approved RNAi medicines on…